Immediate Impact
2 from Science/Nature 55 standout
Citing Papers
Mitochondria-targeted BODIPY dyes for small molecule recognition, bio-imaging and photodynamic therapy
2024 Standout
Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy
2024 Standout
Works of Sally Moore being referenced
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
1999
Phase I study of oral JM216 given twice daily
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Sally Moore | 306 | 69 | 146 | 213 | 148 | 45 | 1.1k | |
| Iftekhar Khan | 341 | 42 | 164 | 359 | 64 | 46 | 1.3k | |
| Gideon Zamba | 437 | 15 | 243 | 154 | 47 | 42 | 1.2k | |
| Amanda Roberts | 330 | 2 | 120 | 334 | 24 | 46 | 1.2k | |
| Gülce Askin | 139 | 18 | 67 | 212 | 30 | 56 | 1.2k | |
| J. W. G. Jacobs | 78 | 199 | 70 | 78 | 76 | 38 | 1.2k | |
| Richa Sharma | 79 | 25 | 85 | 209 | 95 | 64 | 1.1k | |
| Drake G. LeBrun | 307 | 3 | 299 | 100 | 49 | 65 | 1.2k | |
| John J. Lynch | 384 | 20 | 102 | 349 | 25 | 59 | 1.2k | |
| Z.H. Oster | 156 | 47 | 155 | 259 | 50 | 66 | 1.2k | |
| Ji Hye Kim | 90 | 34 | 150 | 392 | 31 | 84 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...